Asparagine endopeptidase can initiate the removal of the MHC class II invariant chain chaperone.

The invariant chain (Ii) chaperone for MHC class II molecules is crucial for their effective function. Equally important is its removal. Cathepsins S or L are known to be required for the final stages of Ii removal in different APCs, but the enzymes which initiate Ii processing have not been identified. Here we show that this step can be performed in B lymphocytes by asparagine endopeptidase (AEP), which targets different asparagine residues in the lumenal domain of human and mouse invariant chain. Inhibition of AEP activity slows invariant chain processing and hinders the expression of an antigenic peptide engineered to replace the groove binding region of Ii (CLIP). However, the initiation of Ii removal can also be performed by other proteases, reflecting the importance of this step.

[1]  C. Watts,et al.  Functional Early Endosomes Are Required for Maturation of Major Histocompatibility Complex Class II Molecules in Human B Lymphoblastoid Cells* , 1999, The Journal of Biological Chemistry.

[2]  A. Lanzavecchia,et al.  Processed antigen binds to newly synthesized mhc class II molecules in antigen-specific B lymphocytes , 1991, Cell.

[3]  L. Arneson,et al.  Efficient endosomal localization of major histocompatibility complex class II-invariant chain complexes requires multimerization of the invariant chain targeting sequence , 1995, The Journal of cell biology.

[4]  Christoph Peters,et al.  Cathepsin L Regulates CD4+ T Cell Selection Independently of Its Effect on Invariant Chain , 2002, The Journal of experimental medicine.

[5]  R. Sékaly,et al.  Invariant chain protects class II histocompatibility antigens from binding intact polypeptides in the endoplasmic reticulum. , 1996, The EMBO journal.

[6]  P. Cresswell,et al.  Invariant chain cleavage and peptide loading in major histocompatibility complex class II vesicles , 1995, The Journal of experimental medicine.

[7]  C. Théry,et al.  Secretory granules of mast cells accumulate mature and immature MHC class II molecules. , 2001, Journal of cell science.

[8]  P. Cresswell,et al.  Structural analysis of proteolytic products of MHC class II-invariant chain complexes generated in vivo. , 1993, Journal of immunology.

[9]  A. Rudensky,et al.  Impaired invariant chain degradation and antigen presentation and diminished collagen-induced arthritis in cathepsin S null mice. , 1999, Immunity.

[10]  J. Neefjes,et al.  Inhibition of endosomal proteolytic activity by leupeptin blocks surface expression of MHC class II molecules and their conversion to SDS resistance alpha beta heterodimers in endosomes. , 1992, The EMBO journal.

[11]  C. Peters,et al.  Degradation of Mouse Invariant Chain: Roles of Cathepsins S and D and the Influence of Major Histocompatibility Complex Polymorphism , 1997, The Journal of experimental medicine.

[12]  R. Mason,et al.  Quantification of cathepsins B and L in cells. , 1998, The Biochemical journal.

[13]  N. Rawlings,et al.  Identification of the active site of legumain links it to caspases, clostripain and gingipains in a new clan of cysteine endopeptidases , 1998, FEBS letters.

[14]  N. Rawlings,et al.  Cloning, Isolation, and Characterization of Mammalian Legumain, an Asparaginyl Endopeptidase* , 1997, The Journal of Biological Chemistry.

[15]  W. Knapp,et al.  Inhibition by leupeptin and antipain of the intracellular proteolysis of Ii. , 1989, Human immunology.

[16]  I. Mellman,et al.  Transient accumulation of new class II MHC molecules in a novel endocytic compartment in B lymphocytes , 1994, Nature.

[17]  A. Barrett,et al.  Inhibition of Mammalian Legumain by Some Cystatins Is Due to a Novel Second Reactive Site* , 1999, The Journal of Biological Chemistry.

[18]  F. Sallusto,et al.  Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha , 1994, The Journal of experimental medicine.

[19]  Partho Ghosh,et al.  The structure of an intermediate in class II MHC maturation: CLIP bound to HLA-DR3 , 1995, Nature.

[20]  P. A. Peterson,et al.  Membrane insertion and oligomeric assembly of HLA-DR histocompatibility antigens , 1982, Cell.

[21]  M. Jackson,et al.  A Role for Acidic Residues in Di-leucine Motif-based Targeting to the Endocytic Pathway (*) , 1995, The Journal of Biological Chemistry.

[22]  H. Horstmann,et al.  Intracellular transport and localization of major histocompatibility complex class II molecules and associated invariant chain , 1991, The Journal of cell biology.

[23]  H. Ploegh,et al.  Mapping functional regions in the lumenal domain of the class II- associated invariant chain , 1994, The Journal of experimental medicine.

[24]  H. Ploegh,et al.  Isolation and characterization of the intracellular MHC class II compartment , 1994, Nature.

[25]  C. Watts,et al.  Antigen processing and class II MHC peptide-loading compartments in human B-lymphoblastoid cells , 1994, Nature.

[26]  S Toba,et al.  Selective targeting of lysosomal cysteine proteases with radiolabeled electrophilic substrate analogs. , 2000, Chemistry & biology.

[27]  H. Davidson,et al.  Endocytosis, intracellular trafficking, and processing of membrane IgG and monovalent antigen/membrane IgG complexes in B lymphocytes. , 1990, Journal of immunology.

[28]  P. Benaroch,et al.  Interaction of MHC class II molecules with the invariant chain: role of the invariant chain (81–90) region , 1997, The EMBO journal.

[29]  P. Cresswell,et al.  Assembly, transport, and function of MHC class II molecules. , 1994, Annual review of immunology.

[30]  A. Rudensky,et al.  Cathepsin L: critical role in Ii degradation and CD4 T cell selection in the thymus. , 1998, Science.

[31]  O. Bakke,et al.  MHC class II-associated invariant chain contains a sorting signal for endosomal compartments , 1990, Cell.

[32]  P. Cresswell,et al.  Assembly and transport properties of invariant chain trimers and HLA-DR-invariant chain complexes. , 1992, Journal of immunology.

[33]  P. Cresswell,et al.  Proteolysis of the class II-associated invariant chain generates a peptide binding site in intracellular HLA-DR molecules. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[34]  H. Ploegh,et al.  Specific role for cathepsin S in the generation of antigenic peptides in vivo , 2002, European journal of immunology.

[35]  H. Chapman,et al.  Cathepsins and compartmentalization in antigen presentation. , 2000, Current opinion in immunology.

[36]  H. Ploegh,et al.  Proteolysis in MHC class II antigen presentation: who's in charge? , 2000, Immunity.

[37]  J. Miller,et al.  MHC class II antigen processing: biology of invariant chain. , 1994, Current opinion in immunology.

[38]  A. Prescott,et al.  Antigen endocytosis and presentation mediated by human membrane IgG1 in the absence of the Igα/Igβ dimer , 1997 .

[39]  N. Viner,et al.  Destructive processing by asparagine endopeptidase limits presentation of a dominant T cell epitope in MBP , 2002, Nature Immunology.

[40]  J. Ashman,et al.  A role for the transmembrane domain in the trimerization of the MHC class II-associated invariant chain. , 1999, Journal of immunology.

[41]  H. Ploegh,et al.  Assembly of HLA DR1 molecules translated in vitro: binding of peptide in the endoplasmic reticulum precludes association with invariant chain. , 1994, The EMBO journal.

[42]  D. Wiley,et al.  Structure of a trimeric domain of the MHC class II‐associated chaperonin and targeting protein Ii , 1998, The EMBO journal.

[43]  M. Zacheis,et al.  Delivery of nascent MHC class II-invariant chain complexes to lysosomal compartments and proteolysis of invariant chain by cysteine proteases precedes peptide binding in B-lymphoblastoid cells. , 1995, Journal of immunology.

[44]  H. Ploegh,et al.  Role for Cathepsin F in Invariant Chain Processing and Major Histocompatibility Complex Class II Peptide Loading by Macrophages , 2000, The Journal of experimental medicine.

[45]  A. Rudensky,et al.  A Role for Cathepsin L and Cathepsin S in Peptide Generation for MHC Class II Presentation1 , 2002, The Journal of Immunology.

[46]  P. Cresswell,et al.  Role for intracellular proteases in the processing and transport of class II HLA antigens. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[47]  Goust Jm,et al.  Major histocompatibility complex. , 1990 .

[48]  R. O’Hehir,et al.  Major histocompatibility complex independent clonal T cell anergy by direct interaction of Staphylococcus aureus enterotoxin B with the T cell antigen receptor , 1992, The Journal of experimental medicine.

[49]  H. Ploegh,et al.  Essential role for cathepsin S in MHC class II-associated invariant chain processing and peptide loading. , 1996, Immunity.

[50]  R. Germain,et al.  MHC class II structure, occupancy and surface expression determined by post-endoplasmic reticulum antigen binding , 1991, Nature.

[51]  Alan J. Barrett,et al.  An asparaginyl endopeptidase processes a microbial antigen for class II MHC presentation , 1998, Nature.

[52]  M. Taylor,et al.  Endosomal aspartic proteinases are required for invariant-chain processing. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[53]  G. Dranoff,et al.  Cathepsin S required for normal MHC class II peptide loading and germinal center development. , 1999, Immunity.

[54]  C. Watts,et al.  Antigen processing in the endocytic compartment. , 2001, Current opinion in immunology.

[55]  R. Germain,et al.  Evidence that binding site occupancy is necessary and sufficient for effective major histocompatibility complex (MHC) class II transport through the secretory pathway redefines the primary function of class II-associated invariant chain peptides (CLIP) , 1996, The Journal of experimental medicine.

[56]  C. Watts,et al.  Control of antigen presentation by a single protease cleavage site. , 2000, Immunity.

[57]  P. Cresswell,et al.  Biosynthesis and glycosylation of the invariant chain associated with HLA-DR antigens. , 1982, Journal of immunology.

[58]  R. Germain,et al.  The CLIP region of invariant chain plays a critical role in regulating major histocompatibility complex class II folding, transport, and peptide occupancy , 1994, The Journal of experimental medicine.

[59]  P. Cresswell,et al.  Formation of a nine-subunit complex by HLA class II glycoproteins and the invariant chain , 1991, Nature.

[60]  P. A. Peterson,et al.  Intracellular transport of class II MHC molecules directed by invariant chain , 1990, Nature.

[61]  P. Cresswell,et al.  Transport and intracellular distribution of MHC class II molecules and associated invariant chain in normal and antigen-processing mutant cell lines , 1994, Journal of Cell Biology.

[62]  P. Benaroch,et al.  Multiple roles of the invariant chain in MHC class II function. , 2002, Biochimica et biophysica acta.

[63]  I. Mellman,et al.  Ii Chain Controls the Transport of Major Histocompatibility Complex Class II Molecules to and from Lysosomes , 1997, The Journal of cell biology.